Effects of ALZ-801, an Oral Amyloid Oligomer Inhibitor, on Biomarkers of Alzheimer’s Disease (AD): 12-Month Results of Phase 2 Biomarker Study in Early AD (S26.007)

Autor:	John Hey, Susan Abushakra, Kaj Blennow, Philip Scheltens, Jakub Hort, Katerina Sheardova, Niels Prins, Sterre Rutgers, Paul Dautzenberg, Ladislav Pazdera, Patrick Kesslak, Rosalind Mandelbaum, Aidan Power, Martin Tolar
Rok vydání:	2023
Zdroj:	Tuesday, April 25.
DOI:	10.1212/wnl.0000000000203129
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e96be3ec8d86f43d71ef009bf3285f50 https://doi.org/10.1212/wnl.0000000000203129 Zobrazit plný text záznamu